Start a discussion
Companies

Novo Nordisk

PharmaceuticalsBagsværd, DenmarkNVO69,505 employees

Start a discussion

WorkHush has 1 source-backed update on Novo Nordisk workforce changes since October 2026. The latest, added October 14, 2026: 108 jobs in Plainsboro, New Jersey from December 31 (WARN notice). The next layoff date on record is December 31, 2026. Read it with sources ›

What the sources say

The source-backed update ›

108 jobs in Plainsboro, New Jersey from December 31

WARN notice · WARN notice posted in September 2026 (New Jersey DOL); layoffs from December 31, 2026

Sources: New Jersey DOL WARN notices

Next layoff dateDec 31108 jobs in Plainsboro, New Jersey from December 31
More about Novo Nordisk

Drugmaker that develops and sells medicines for diabetes, obesity and rare diseases

Revenue
DKK 309.1B
Fiscal 2025, up 6.4%
Employees
69,505
As of December 2025
Stock
NVO
New York Stock Exchange
Headquarters
Bagsværd, Denmark
CEO
Maziar Mike Doustdar
Since August 2025
BrandsOzempic, Wegovy, Rybelsus, NovoRapid
Current strategyReallocating resources toward growth in obesity and diabetes after a company-wide transformation
Recent workforce changesAbout 9,000 jobs cut globally in a restructuring announced in September 2025, largely completed by end of 2025
CompetitorsEli Lilly, Sanofi, AstraZeneca
Related companiesEli LillySanofiAmgen

Checked October 11, 2026 · Sources: sec.gov, fiercepharma.com

Be the first to post about Novo Nordisk

No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.

Be the first to post

Or follow Novo Nordisk to see the first post in your watchlist.

Follow Novo Nordisk in a feed reader, no account needed: RSS feed